title: Double-blind placebo-controlled randomized clinical trial of verapamil for chronic rhinosinusitis with nasal polyps.
authors.affiliation: Division of Rhinology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass; Department of Otolaryngology, Santa Casa de Sao Paulo School of Medical Sciences, Sao Paulo, Brazil.
authors.forename: Marcel M
authors.initials: MM
authors.lastname: Miyake
authors.affiliation: Division of Rhinology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass.
authors.forename: Angela
authors.initials: A
authors.lastname: Nocera
authors.affiliation: Division of Rhinology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass.
authors.forename: Patricia
authors.initials: P
authors.lastname: Levesque
authors.affiliation: Division of Biostatistics, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass.
authors.forename: Rong
authors.initials: R
authors.lastname: Guo
authors.affiliation: Department of Pharmacy, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass.
authors.forename: Christine A
authors.initials: CA
authors.lastname: Finn
authors.affiliation: Department of Anesthesiology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Goldfarb
authors.affiliation: Division of Rhinology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass.
authors.forename: Stacey
authors.initials: S
authors.lastname: Gray
authors.affiliation: Division of Rhinology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass.
authors.forename: Eric
authors.initials: E
authors.lastname: Holbrook
authors.affiliation: Division of Rhinology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Busaba
authors.affiliation: Department of Otolaryngology, Santa Casa de Sao Paulo School of Medical Sciences, Sao Paulo, Brazil.
authors.forename: Jose Eduardo L
authors.initials: JEL
authors.lastname: Dolci
authors.affiliation: Division of Rhinology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass. Electronic address: benjamin_bleier@meei.harvard.edu.
authors.forename: Benjamin S
authors.initials: BS
authors.lastname: Bleier
mesh_terms: D016022:Case-Control Studies; D002908:Chronic Disease; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009298:Nasal Polyps / Q000188:drug therapy*; D012220:Rhinitis / Q000188:drug therapy* / Q000473:pathology*; D012852:Sinusitis / Q000188:drug therapy* / Q000473:pathology*; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007155:Immunologic Factors; D014700:Verapamil